Cargando…

Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy

BACKGROUND: Patients with chronic kidney disease (CKD) or kidney replacement therapy demonstrate lower antibody levels after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination compared with healthy controls. In a prospective cohort, we analysed the impact of immunosuppressive t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bouwmans, Pim, Messchendorp, A Lianne, Imhof, Céline, Sanders, Jan-Stephan F, Hilbrands, Luuk B, Reinders, Marlies E J, Vart, Priya, Bemelman, Frederike J, Abrahams, Alferso C, van den Dorpel, René M A, Ten Dam, Marc A G J, de Vries, Aiko P J, Rispens, Theo, Steenhuis, Maurice, Gansevoort, Ron T, Hemmelder, Marc H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972832/ https://www.ncbi.nlm.nih.gov/pubmed/36865021 http://dx.doi.org/10.1093/ckj/sfac249

Ejemplares similares

Predictors of Nonseroconversion to SARS-CoV-2 Vaccination in Kidney Transplant Recipients
por: Frölke, Sophie C., et al.
Publicado: (2022)

Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study
por: Bouwmans, P., et al.
Publicado: (2022)

Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire study
por: Frölke, Sophie C., et al.
Publicado: (2023)

SARS-CoV-2 Spike-specific IFN-γ T-cell Response After COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
por: Imhof, Céline, et al.
Publicado: (2022)

The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant
por: Kho, Marcia M L, et al.
Publicado: (2021)

Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial
por: Kho, Marcia M L, et al.
Publicado: (2023)

Vaccinated kidney transplant recipients are yet not sufficiently protected against COVID-19
por: Messchendorp, A Lianne, et al.
Publicado: (2023)

The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
por: Sanders, Jan-Stephan F., et al.
Publicado: (2021)

The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients
por: Malahe, S. Reshwan K., et al.
Publicado: (2023)

Pitfalls when comparing COVID-19-related outcomes across studies—lessons learnt from the ERACODA collaboration
por: Noordzij, Marlies, et al.
Publicado: (2021)

Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
por: Sanders, Jan-Stephan F, et al.
Publicado: (2022)

Th(1)-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses
por: den Hartog, Yvette, et al.
Publicado: (2023)

The Clinical Frailty Scale as a triage tool for ICU admission of dialysis patients with COVID-19: an ERACODA analysis
por: Bouwmans, Pim, et al.
Publicado: (2022)

COVID-19 Pandemic Waves and Mortality Among Patients on Kidney Replacement Therapy
por: Vart, Priya, et al.
Publicado: (2022)

Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA
por: Hemmelder, Marc H, et al.
Publicado: (2022)

The Time-Dependent Association of Torque Teno Virus Load with the Level of SARS-CoV-2 S1 IgG Antibodies Following COVID-19 Vaccination in Kidney Transplant Recipients
por: Imhof, Céline, et al.
Publicado: (2023)

Informing clinical decision making during a pandemic — a call for better preparedness
por: Vart, Priya, et al.
Publicado: (2023)

Association of obesity with 3-month mortality in kidney failure patients with COVID-19
por: Tantisattamo, Ekamol, et al.
Publicado: (2022)

Employment and ability to work after kidney transplantation in the Netherlands: The impact of preemptive versus non‐preemptive kidney transplantation
por: Visser, Annemieke, et al.
Publicado: (2022)

Somatostatin in renal physiology and autosomal dominant polycystic kidney disease
por: Messchendorp, A Lianne, et al.
Publicado: (2019)

COVID-19 Vaccination Response in Kidney Transplant Recipients With and Without Mycophenolate Mofetil: Follow-up of a Randomized Controlled Trial
por: Al Fatly, Zainab, et al.
Publicado: (2022)

Erratum to: COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration
por: Hilbrands, Luuk B, et al.
Publicado: (2021)

Strategies to prevent SARS-CoV-2 transmission in hemodialysis centres across Europe—lessons for the future
por: Noordzij, Marlies, et al.
Publicado: (2022)

Preparing European Nephrology for the next pandemic: lessons from the ERACODA collaboration
por: Vart, Priya, et al.
Publicado: (2022)

Implementation of the kidney team at home intervention: Evaluating generalizability, implementation process, and effects
por: Redeker, Steef, et al.
Publicado: (2021)

Surrogate Endpoints for Late Kidney Transplantation Failure
por: Naesens, Maarten, et al.
Publicado: (2022)

Can We Predict Graft Intolerance Syndrome After Kidney Transplant Failure? External Validation of a Previously Developed Model
por: Bunthof, Kim, et al.
Publicado: (2023)

Differences in mental health status during the COVID-19 pandemic between patients undergoing in-center hemodialysis and peritoneal dialysis
por: Bouwmans, Pim, et al.
Publicado: (2023)

Considerable Variability Among Transplant Nephrologists in Judging Deceased Donor Kidney Offers
por: Schutter, Rianne, et al.
Publicado: (2023)

T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease
por: van Gastel, Maatje D. A., et al.
Publicado: (2017)

Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation
por: Hilbrands, Luuk, et al.
Publicado: (2022)

CKD is a key risk factor for COVID-19 mortality
por: Gansevoort, Ron T., et al.
Publicado: (2020)

Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation
por: Naesens, Maarten, et al.
Publicado: (2022)

Histopathological examination of removed kidney allografts: Is it useful? A retrospective cohort study
por: Bunthof, Kim L.W., et al.
Publicado: (2020)

Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy
por: Vart, Priya, et al.
Publicado: (2022)

Dialysis withdrawal in The Netherlands between 2000 and 2019: time trends, risk factors and centre variation
por: van Oevelen, Mathijs, et al.
Publicado: (2021)

Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression
por: Messchendorp, A. Lianne, et al.
Publicado: (2017)

Equivalent Long-term Transplantation Outcomes for Kidneys Donated After Brain Death and Cardiac Death: Conclusions From a Nationwide Evaluation
por: Schaapherder, Alexander, et al.
Publicado: (2018)

COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study
por: Goffin, Eric, et al.
Publicado: (2021)

Understanding Health-Related Quality of Life in Kidney Transplant Recipients: The Role of Symptom Experience and Illness Perceptions
por: Wang, Yiman, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r06tlua8o8o3vh3gjsv8j2k0t4